Clinical Trial Update: To Observe the CD7-targeted CAR-T Therapy in the Treatment of MRD Positive T-ALL/LBL Post Allo-HSCT [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial is evaluating CD7-targeted CAR-T therapy for patients with MRD-positive T-cell acute lymphoblastic leukemia or lymphoblastic lymphoma a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoblastic Lymphoma
• T-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• CD7-targeted CAR-T therapy

Snippet

Sponsor: Peking University People's Hospital | Conditions: CD7+ T-ALL/LBL | Phase 1 | Status: RECRUITING